Apimeds Pharmaceuticals US, Inc. — All Filings
106 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
3
3/A
4
4/A
424B4
425
8-A12B
8-K
8-K/A
CERT
CORRESP
DEFM14C
DRS
DRS/A
DRSLTR
EFFECT
FWP
NT 10-K
NT 10-Q
POS AM
PREM14C
S-1
S-1/A
S-8
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DRSLTR | — | 0001213900-24-053081 | Jun 14, 2024 | — |
| UPLOAD | — | 0000000000-24-006001 | May 23, 2024 | — |
| DRSLTR | — | 0001213900-24-042400 | May 13, 2024 | — |
| DRS/A | — | 0001213900-24-042397 | May 13, 2024 | — |
| UPLOAD | — | 0000000000-24-002122 | Feb 26, 2024 | — |
| DRS | — | 0001213900-24-007296 | Jan 29, 2024 | — |